Ubs Group Ag Applied Genetic Technologies Corp Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.29 - $0.89 $13,621 - $41,804
46,971 Added 398.23%
58,766 $16,000
Q2 2022

Aug 10, 2022
BUY
$0.62 - $1.1 $7,312 - $12,974
11,795 New
11,795 $9,000
Q3 2021

Nov 15, 2021
SELL
$3.01 - $4.12 $5,029 - $6,884
-1,671 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$3.62 - $5.23 $30,751 - $44,428
-8,495 Reduced 83.56%
1,671 $7,000
Q1 2021

May 12, 2021
BUY
$3.94 - $8.19 $19,077 - $39,655
4,842 Added 90.95%
10,166 $52,000
Q4 2020

Feb 11, 2021
BUY
$3.99 - $5.7 $21,075 - $30,107
5,282 Added 12576.19%
5,324 $22,000
Q3 2020

Nov 12, 2020
SELL
$4.38 - $6.43 $32,433 - $47,614
-7,405 Reduced 99.44%
42 $0
Q2 2020

Jul 31, 2020
BUY
$3.0 - $6.9 $15,618 - $35,921
5,206 Added 232.31%
7,447 $41,000
Q1 2020

May 01, 2020
BUY
$2.36 - $9.86 $4,170 - $17,422
1,767 Added 372.78%
2,241 $7,000
Q4 2019

Feb 14, 2020
SELL
$2.69 - $4.92 $9,751 - $17,835
-3,625 Reduced 88.44%
474 $2,000
Q3 2019

Nov 14, 2019
SELL
$2.59 - $4.16 $34,086 - $54,749
-13,161 Reduced 76.25%
4,099 $17,000
Q2 2019

Aug 14, 2019
SELL
$3.6 - $4.78 $10,224 - $13,575
-2,840 Reduced 14.13%
17,260 $65,000
Q1 2019

May 14, 2019
SELL
$2.62 - $4.44 $4,650 - $7,881
-1,775 Reduced 8.11%
20,100 $84,000
Q4 2018

Feb 14, 2019
BUY
$2.28 - $7.15 $49,874 - $156,406
21,875 New
21,875 $54,000
Q3 2018

Nov 14, 2018
SELL
$3.85 - $7.35 $1,420 - $2,712
-369 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$3.7 - $5.65 $8,495 - $12,972
-2,296 Reduced 86.15%
369 $1,000
Q1 2018

May 15, 2018
SELL
$3.65 - $5.2 $36,554 - $52,078
-10,015 Reduced 78.98%
2,665 $10,000
Q4 2017

Feb 14, 2018
BUY
$3.4 - $4.15 $43,112 - $52,622
12,680 New
12,680 $46,000
Q3 2017

Nov 14, 2017
SELL
$3.55 - $5.25 $112,545 - $166,440
-31,703 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
30,871 Added 3710.46%
31,703 $161,000
Q1 2017

Nov 14, 2017
BUY
N/A
832
832 $6,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email